An increasing curve of new hypertriglyceridemia drugs

New hypertriglyceridemia drugs are drawing attention in the pharmaceutical market.

Hypertriglyceridemia is one of the dyslipidemias, which is more common than hypercholesteremia and which must requires appropriate medication treatment if dietary controls and exercise cures are not applicable.

According to the pharmaceutical industry, it is highly common in the foreign major guidelines to pres...